The association between plasma d-dimer levels and community-acquired pneumonia

Clinics

Volumn 65, Issue 6, 2010, Pages 593-597

  Arslan, Sulhattin ^a   Ugurlu, Serdal ^b   Bulut, Gokten ^a   Akkurt, Ibrahim ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Community acquired pneumonia; D dimer; Pneumonia severity

Indexed keywords

BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ARTICLE; BLOOD; BRAZIL; CASE CONTROL STUDY; COMMUNICABLE DISEASE; FEMALE; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PNEUMONIA; SURVIVAL RATE;

BIOLOGICAL MARKERS; BRAZIL; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 77954888718     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000600006     Document Type: Article

References (21)

1. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med. 2001;163:1730-54.
2. Özlü T, Bülbül Y, Özsu S. Ulusal Verilerle Toplum Kökenli Pnömoniler. Tüberküloz ve Toraks Dergisi. 2007;55:191-212.
3. Gribaldi RA. Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology and impact. Am J Med. 1985;78:32-7.
4. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. İnfectiuous Diseases Society Of American /ATS consensus Guidelines on the management of community-acquired pneumonia adults. Clin İnfect Dis. 2007;44:27-72.
5. Freyburger G, Trillaud H, Labrouche S, Gauther P, Javorschi S, Bernard P, et al. D-dimer strategy in thrombosis exclusion--a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost. 1998;79:32-7.
6. Weiner SG, Burstein JL. Nonspecific tests for pulmonary embolism. Emergency Medicine Clinics of North America. 2003;19:943-55.
7. Bayes-Genis A, Mateo J, Santalo M, Oliver A, Badimon GJ, Martinez-Rubio A, et al. D-dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. American Heart Journal. 2000;140:379-84.
8. Chabloz P, Reber G, Boehlen F, Hohlfeld P, De Moerloose P. TAFI antigen and D-dimer levels during normal pregnancy and at delivery. British Journal of Haematology. 2001; 115:150-2.
9. Günther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Am J Respir Crit Care Med. 2000;161:454-62.
10. Fine MJ, Auble TE, Yealye DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 23:243-50.
11. Mandell AL, Wunderink RG, Anzueto A, Bartlett JG, G. Campbell D, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis. 2007;44 (Suppl 2):S27-S72.
12. Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 2000;31: 347-82.
13. Kobzik L. The lung. In: Robbins SL, Cotran RS, Kumar V, Collins T (eds). Robbins Pathologic Basis of Disease. 6th ed. WB. Saunders. 1999:697-755.
14. Deitcher SR, Eisenberg PR: Elevated concentrations of cross-linked fibrin degradation products in plasma. Chest. 1993;103:1107-12.
15. Quick G, Eisenberg P: Bedside measurement of D-dimer in the identification of bacteremia in the emergency department. J Emerg Med. 2000;19:217-23.
16. Shilon Y, Shitrit ABG, Rudensky B, Yi{dotless}nnon M, Margalit M, Sulkes J, et al. A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia. Blood Coagulation and Fibrinolysis. 2003;14:745-8.
17. Guneysel O, Pirmit S, Karakurt S. Plasma D-dimer levels increase with the severity of community acquired pneumonia. Tuberkuloz ve Toraks Dergisi. 2004;52:341-7.
18. Ribelles JMQ, Tenias JM, Grau E, Borras JMQ, Climent JR, Gomez E, et al. Plasma D-dimer levels correlate with outcomes in patients with community acquired pneumonia. Chest 2004;124:1087- 92.
19. Chalmers JD, Singanayagam A, Scally C, Hill AT. Admission D-dimer Can Identify Low-Risk Patients With Community-Acquired Pneumonia. Annals of Emergency Medicine. 2009;53:633-8.
20. Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med. 2003;31:238-42.
21. Shorr AF, Trotta RF, Alkins SA, Hanzel GS, Diehl LF. D-dimer assay predicts mortality in critically ill patients without disseminated intravascular or venous thromboembolic disease. Intensive Care Med. 1999;25:207- 10.